Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site (original) (raw)
- Original Paper
- Published: 05 June 1997
- Lothar Schleithoff2 na1 nAff4,
- Ansgar S Schulz2,
- Heidi Kessler2,
- Reiner Lammers3 nAff5,
- Axel Ullrich3,
- Claus R Bartram1,2 &
- …
- Johannes WG Janssen1,2
Oncogene volume 14, pages 2619–2631 (1997)Cite this article
- 2389 Accesses
- 9 Altmetric
- Metrics details
Abstract
Ufo/Axl belongs to a new family of receptor tyrosine kinases with an extracellular structure similar to that of neural cell adhesion molecules. In order to elucidate intracellular signaling, the cytoplasmic moiety of Ufo/Axl was used to screen an expression library according to the CORT (cloning of receptor targets) method. Three putative Ufo substrates were identified: phospholipase Cγ1 (PLCγ), as well as p85α and p85β subunits of phosphatidylinositol 3′-kinase (PI3-kinase). Subsequently, chimeric EGFR/Ufo receptors consisting of the extracellular domains of the epidermal growth factor receptor (EGFR) and the transmembrane and intracellular moiety of Ufo were engineered. Using different far-Western blot analyses and coimmunoprecipitation assays, receptor binding of PLCγ and p85 proteins as well as GRB2, c-src and lck was examined in vitro and in vivo. Competitive inhibition of substrate binding and mutagenesis experiments with EGFR/Ufo constructs revealed C-terminal tyrosine 821 (EILpYVNMDEG) as a docking site for multiple effectors, namely PLCγ, p85 proteins, GRB2, c-src and lck. Tyrosine 779 (DGLpYALMSRC) demonstrated an additional, but lower binding affinity for the p85 proteins in vitro. In addition, binding of PLCγ occurred through tyrosine 866 (AGRpYVLCPST). Moreover, our in vivo data indicate that further direct or indirect binding sites for PLCγ, GRB2, c-src and lck on the human Ufo receptor may exist.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Author notes
- Lothar Schleithoff
Present address: Abteilung für Angewandte Physiologie, Universität Ulm, Albert-Einstein-Allee 11, Ulm, 89081, Germany - Reiner Lammers
Present address: Medizinische Linik und Poliklinik, Eberhard-Karls-Universität Tübingen, Otfried-Müller-Straße 10, Tübingen, 72076, Germany - Jürgen Braunger and Lothar Schleithoff: The first two authors contributed equally to this work
Authors and Affiliations
- Institut für Humangenetik, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 328, Heidelberg, 69120, Germany
Jürgen Braunger, Claus R Bartram & Johannes WG Janssen - Abteilung Kinderheilkunde II, Universität Ulm, Prittwitzstraße 43, Ulm, 89075, Germany
Jürgen Braunger, Lothar Schleithoff, Ansgar S Schulz, Heidi Kessler, Claus R Bartram & Johannes WG Janssen - Max-Planck-Institut für Biochemie, Am Klopferspitz 18A, Martinsried, 82152, Germany
Reiner Lammers & Axel Ullrich
Authors
- Jürgen Braunger
You can also search for this author inPubMed Google Scholar - Lothar Schleithoff
You can also search for this author inPubMed Google Scholar - Ansgar S Schulz
You can also search for this author inPubMed Google Scholar - Heidi Kessler
You can also search for this author inPubMed Google Scholar - Reiner Lammers
You can also search for this author inPubMed Google Scholar - Axel Ullrich
You can also search for this author inPubMed Google Scholar - Claus R Bartram
You can also search for this author inPubMed Google Scholar - Johannes WG Janssen
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Braunger, J., Schleithoff, L., Schulz, A. et al. Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site.Oncogene 14, 2619–2631 (1997). https://doi.org/10.1038/sj.onc.1201123
- Received: 23 December 1996
- Revised: 28 February 1997
- Accepted: 28 February 1997
- Issue Date: 05 June 1997
- DOI: https://doi.org/10.1038/sj.onc.1201123